Route-dependent effects of the non-NMDA receptor antagonist CNQX on plasma corticosterone levels in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 6, 2003, Pages 1055-1058

  Kim, Do Hoon ^a   Moon, Yoo Sun ^a   Jung, Jun Sub ^a   Suh, Hong Won ^a   Song, Dong Keun ^a  

^a Hallym University   (South Korea)

Author keywords

6 Cyano 7 nitro quinoxaline 2,3 dione; Intracerebroventricular injection; Intraperitoneal injection; Plasma corticosterone

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CORTICOSTERONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; STRESS;

EID: 0141628386     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00147-7     Document Type: Article

References (14)

1. Costa A., Yasin S.A., Hucks D., Forsling M.L., Besser G.M., Grossman A. Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants. Endocrinology. 131:1992;2595-2602.
2. Czlonkowska A., Siemiatkowski M., Plaznik A. Some behavioral effects of AMPA/kainate receptor agonist and antagonists. J. Physiol. Pharmacol. 48:1997;479-488.
3. Farah J.M. Jr., Rao T.S., Mick S.J., Coyne K.E., Iyengar S. N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology. 128:1991;1875-1880.
4. Fink-Jensen A., Judge M.E., Hansen J.B., Jacobsen P., Turski L., Olney J., Honore T. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX. Neurosci. Lett. 137:1992;173-177.
5. Glick D., Redlich D., Levine S. Fluorometric determination of corticosterone and cortisol in 0.02-0.05 ml of plasma or submilligram samples of adrenal tissue. Endocrinology. 74:1964;653-655.
6. Hinoi E., Yoneda Y. Expression of GluR6/7 subunits of kainate receptors in rat adenohypophysis. Neurochem. Int. 38:2001;539-547.
7. Hinoi E., Fujimori S., Takemori A., Kurabayashi H., Nakamura Y., Yoneda Y. Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts. Brain Res. 943:2002;112-116.
8. Jezova D., Oliver C., Jurcovicova J. Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology. 54:1991;488-492.
9. Kristensen P. Differential expression of AMPA glutamate receptor mRNAs in the rat adrenal gland. FEBS Lett. 332:1993;14-18.
10. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods. 16:1986;355-357.
11. Molina P.E., Tepper P.G., Yousef K.A., Abumrad N.N., Lang C.H. Central NMDA enhances hepatic glucose output and non-insulin-mediated glucose uptake by a nonadrenergic mechanism. Brain Res. 634:1994;41-48.
12. Yoshiyama M., Roppolo J.R., de Groat W.C. Effects of GYKI 52466 and CNQX, AMPA/kainate receptor antagonists, on the micturition reflex in the rat. Brain Res. 691:1995;185-194.
13. Yousef K.A., Tepper P.G., Molina P.E., Abumrad N.N., Lang C.H. Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate. Brain Res. 634:1994;131-140.
14. Zelena D., Makara G.B., Jezova D. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release. Neuroendocrinology. 69:1999;316-323.